SELENON and myopathy: These results indicate that SELENON may have evolved as part of an ER stress-dependent anti-oxidant response in active muscles, and that the CHOP-ERO1 branch of the ER stress response provides a novel pathogenic mechanism underlying SELENON-related myopathies.